Key Moments
Testosterone replacement therapy: compelling use cases, side effects, and optimal dosing schedules
Key Moments
TRT offers benefits for hypogonadism, but optimal dosing and frequency are key to managing side effects and maximizing results.
Key Insights
Testosterone levels naturally decline with age, but consulting a doctor is crucial before considering TRT.
Primary hypogonadism (testicular failure despite adequate signaling) is the most compelling reason for TRT.
Dosing frequency significantly impacts hormone stability and can mitigate side effects like gynecomastia.
Subcutaneous injections may offer a more sustained release compared to intramuscular injections.
FDA-approved formulations can be preferable to compounded versions, offering standardized dosing and quality.
Personalized TRT regimens are essential, considering individual responses, lifestyle, and goals.
NATURAL DECLINE VS. CONSIDERATION FOR TRT
Testosterone levels naturally decrease with age, typically starting around 30-35, with an estimated 1% drop in total testosterone and 2-3% in free testosterone per year. However, this decline is gradual and can vary significantly among individuals; some older men retain high testosterone levels. It's crucial not to assume a diagnosis based on age alone. Consulting a healthcare professional is essential to assess individual levels, understand contributing factors like lifestyle, sleep, and nutrient intake, and determine if TRT is appropriate rather than solely relying on age-related expectations.
COMPELLING USE CASES FOR TRT
The most medically justified reason for TRT is primary hypogonadism, where the testes fail to respond adequately to hormonal signals (high LH and FSH) despite sufficient signaling from the pituitary gland. This condition can sometimes be linked to structural or functional testicular abnormalities, such as varicoceles, which should be investigated. In contrast, secondary hypogonadism, characterized by low testosterone with low LH and FSH, often points to issues like poor sleep or elevated cortisol levels, which may be addressed through lifestyle changes rather than TRT.
OPTIMAL DOSING STRATEGIES AND FREQUENCY
While fixed dosing is common, optimal TRT likely involves a dynamic approach. A reasonable starting point for exogenous testosterone, such as testosterone cypionate, ranges from 80-120 mg per week, with adjustments based on individual response and symptom relief. However, dosing frequency is critical for stable hormone levels. Splitting doses from once weekly to twice weekly, or even daily, can significantly reduce hormonal spikes, minimize conversion to estrogen and DHT, and lower the risk of side effects like gynecomastia and sleep disturbances.
IMPACT OF INJECTION FREQUENCY ON SIDE EFFECTS
Infrequent injections (e.g., once weekly) can lead to supraphysiological testosterone peaks, concurrently increasing estrogen and DHT conversion and potentially causing sympathetic nervous system activation, sleep disruption, and increased red blood cell production (hematopoiesis). More frequent dosing regimens, such as twice weekly or daily, more closely mimic natural hormonal rhythms. This approach can reduce aromatization, lower DHT conversion, and allow individuals to potentially discontinue aromatase inhibitors, thereby improving overall hormonal balance and reducing side effect burden.
SUBQ VS. INTRAMUSCULAR INJECTIONS
The method of testosterone administration also plays a role in its pharmacokinetic profile. Subcutaneous (subQ) injections, particularly with less frequent dosing, may provide a more sustained release of testosterone compared to intramuscular (IM) injections, which are absorbed more rapidly due to higher blood flow. While definitive data is limited, the perception is that subQ may lead to more stable total testosterone levels over time. For individuals undergoing frequent dosing schedules, the difference between subQ and IM may become less significant.
FDA-APPROVED FORMULATIONS AND PERSONALIZED APPROACHES
Opting for FDA-approved formulations, like those available in pre-loaded pens such as Zast (testosterone enanthate), can offer convenience and standardized dosing, especially for individuals hesitant about self-injection. However, these may come at a higher cost and offer less flexibility in dose titration compared to injectable vials of testosterone cypionate. Ultimately, the most effective TRT regimen is personalized, considering individual metabolic responses, adherence to protocol, lifestyle factors, and the pursuit of stable hormone levels with a minimized side effect profile.
Mentioned in This Episode
●Supplements
●Products
●Tools
●Concepts
TRT Dosing and Administration Best Practices
Practical takeaways from this episode
Do This
Avoid This
Common Questions
Normal testosterone levels can vary, but generally, total testosterone levels are often cited in ranges like 300-1000 ng/dL. However, the interpretation is complex as free testosterone and age are crucial factors, and lab ranges can be broad.
Topics
Mentioned in this video
A brand name for an auto-injector pen containing testosterone enanthate, designed for ease of use but with limited dosing flexibility.
Refers to the unbound, biologically active form of testosterone, which is difficult to measure directly and is often estimated.
A commonly prescribed ester of testosterone for TRT, with a long half-life (around 10 days) that influences injection frequency.
An ester of testosterone with a half-life typically shorter than cypionate, often used in TRT and available in pre-loaded pens like Zestica.
The overall amount of testosterone in the blood, including bound and unbound forms. Used to estimate free testosterone levels.
Medications used to reduce the conversion of testosterone to estrogen, sometimes prescribed alongside TRT to manage side effects like gynecomastia.
Receptors in the body that bind with androgens like testosterone, mediating their effects. The number of these receptors influences how much testosterone is needed.
A condition characterized by the testes not responding adequately to gonadotropin signaling (LH and FSH), resulting in low testosterone despite normal or high pituitary signals.
More from Peter Attia MD
View all 121 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free